The BRAF V600E mutation has been identified in multiple tumors, including melanoma, pleomorphic xanthoastrocytoma (PXA), ganglioglioma and papillary craniopharyngioma [3, 15, 18, 19]. Here, BRAF is linked to pleomorphic xanthoastrocytoma.